oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Atorvox

An error on the outer packaging (simultaneous strength markings 40 mg and 20 mg) may lead to incorrect dispensing from the pharmacy and improper dosing by patients, which may pose a risk to life or health. Potential effects: improper statin dosing, cardiovascular complications or adverse reactions.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Atorvox
Risk Level
Critical
Manufacturer
Teva Pharmaceuticals Polska Sp. z o.o.
Batch Number
21212
EAN Code
05909990573547
Recall Date
24.03.2022
View official statement

Important Information

What You Should Know

Recommendations

Do not use Atorvox 40 mg with batch number 21212, check the batch number on the packaging and return the medicine to the pharmacy; if in doubt about the dose, contact a doctor or pharmacist.

Actions Taken

The Chief Pharmaceutical Inspector withdrew Atorvox 40 mg, film-coated tablets, batch 21212, from the market throughout the country and granted the decision immediate enforceability; the marketing aut...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: An error on the outer packaging (simultaneous strength markings 40 mg and 20 mg) may lead to incorrect dispensing from the pharmacy and improper dosing by patients, which may pose a risk to life or health. Potential effects: improper statin dosing, cardiovascular complications or adverse reactions.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: 21212

Related

Other Recalled Products